FDA Inspection 1281578 — Genzyme Corporation

Genzyme Corporation — FEI 3009389940

The FDA completed an inspection of Genzyme Corporation on August 14, 2025 in Northborough, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Northborough, MA (United States)